Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CI
CI logo

CI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
287.314
Open
284.200
VWAP
280.28
Vol
2.40M
Mkt Cap
73.38B
Low
276.140
Amount
672.73M
EV/EBITDA(TTM)
7.13
Total Shares
264.53M
EV
96.66B
EV/OCF(TTM)
10.97
P/S(TTM)
0.27
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
Show More

Events Timeline

(ET)
2026-05-20
11:50:00
Major Averages Rise as Semiconductor Stocks Rebound
select

News

seekingalpha
7.5
05-28seekingalpha
Cost Analysis of Direct-to-Consumer Pharmacies for Generic Drugs
  • Cost Savings on Medications: An analysis by the University of Texas MD Anderson Cancer Center reveals that consumers using Mark Cuban Cost Plus Drug pay less out-of-pocket for approximately 80% of prescriptions when their cost-sharing exceeds $15, leading to significant savings.
  • Impact of High Cost-Sharing: For consumers with drug plan benefits that require more than $100 in cost-sharing, the median out-of-pocket cost is $25 with Cost Plus Drug compared to $140 with insurance, highlighting the clear advantages of direct-to-consumer pharmacies.
  • Data-Driven Insights: The findings are based on an examination of over 60 million generic prescription claims from a national commercial claims database, ensuring the reliability and broad applicability of the results, which emphasize potential savings for consumers when choosing their medication payment methods.
  • Consumer Recommendations: Researchers advise that consumers should consider direct-to-consumer pharmacies if their out-of-pocket costs exceed $15, optimizing their medication expenses and enhancing economic efficiency.
NASDAQ.COM
4.5
05-26NASDAQ.COM
US Stocks Close Higher: S&P 500 Hits All-Time High
  • Market Performance: The S&P 500 rose by 0.61% and the Nasdaq 100 increased by 1.76%, reaching all-time highs, indicating strong demand for tech stocks amid falling oil prices and progress in US-Iran peace talks.
  • Oil Price Volatility: WTI crude oil prices fell to a 2.5-week low as US-Iran negotiations aimed at reopening the Strait of Hormuz progressed, although military actions by US Central Command pressured market sentiment, leading to declines in energy stocks.
  • Economic Data Impact: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while a slight decline in the consumer confidence index reflects the complexities of economic recovery, potentially influencing future market trends.
  • Earnings Reports: As of Tuesday, 83% of the 475 S&P 500 companies reported earnings above expectations, with Q1 earnings projected to grow by 12% year-on-year, although excluding the tech sector, the increase is only 3%, highlighting disparities across industries.
NASDAQ.COM
4.5
05-26NASDAQ.COM
US Stock Indices Rally, Led by Technology Stocks
  • Strong Market Performance: The S&P 500 Index rose by 0.81% and the Nasdaq 100 Index increased by 1.74%, reaching all-time highs, indicating robust market support for technology stocks, particularly amid falling crude oil prices and declining bond yields.
  • Mixed Economic Data: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while the S&P Composite-20 home price index increased by only 0.83% year-on-year, below the expected 0.90%, suggesting weakness in the housing market that could impact future consumer confidence.
  • Volatile Oil Market: WTI crude oil prices fell to a 2.5-week low due to progress in US-Iran peace talks, although US Central Command's strikes on Iranian targets caused market fluctuations, highlighting the ongoing geopolitical influence on energy markets.
  • Earnings Season Insights: So far, 83% of the 475 S&P 500 companies have beaten earnings estimates, with Q1 earnings projected to rise by 12% year-on-year; however, excluding the technology sector, the increase is only 3%, reflecting pressure on overall economic growth.
NASDAQ.COM
4.5
05-26NASDAQ.COM
US Stocks Rally as Oil Prices Drop Amid Iran Talks
  • Strong Market Performance: The S&P 500 index rose by 0.72% and the Nasdaq 100 by 1.42%, reaching all-time highs, reflecting market confidence in economic recovery, particularly against the backdrop of falling oil prices and declining bond yields.
  • Oil Price Volatility: WTI crude oil prices fell to a 2.5-week low, dropping over 3% today, primarily influenced by progress in US-Iran peace talks, although military actions by US Central Command have added pressure to market sentiment.
  • Mixed Economic Data: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, exceeding expectations, while the S&P Composite-20 home price index increased by only 0.83% y/y, below the expected 0.90%, indicating weakness in the housing market.
  • Earnings Reports: So far, 83% of the 475 S&P 500 companies have beaten earnings estimates, with Q1 earnings projected to rise by 12% y/y, but excluding the tech sector, the increase is only 3%, the lowest in two years, highlighting disparities across industries.
seekingalpha
6.0
05-26seekingalpha
Barclays Downgrades Cigna to Equal-Weight Amid Limited Upside
  • Rating Downgrade Impact: Barclays downgraded Cigna from overweight to equal-weight, indicating limited upside potential for the stock, reflecting a cautious market outlook on its future performance.
  • Price Target Analysis: Barclays set a price target of $304 for Cigna, which translates to approximately 6% upside based on the May 22 close, highlighting investor concerns regarding its profitability.
  • Uncertain Earnings Outlook: Analyst Andrew Mok noted that while the prospects for health insurance margin recovery are underway, Cigna has limited embedded earnings and multiple upside potential, particularly given its low government exposure.
  • Transition Uncertainty: The lack of clarity regarding Cigna's pharmacy benefits manager model transition, coupled with concerns over easing investment spending, may negatively impact its future financial performance.
Yahoo Finance
9.5
05-24Yahoo Finance
Cigna Group Rated Among Top Dividend Growth Stocks
  • Dividend Growth Potential: With a 5-year dividend growth rate of 42.40%, Cigna Group is recognized as one of the 10 Best Dividend Growth Stocks to Buy and Hold for 3 Years, showcasing its strong performance and appeal in dividend returns.
  • Analyst Rating Upgrade: UBS raised its price target on Cigna Group from $375 to $400 while reiterating a Buy rating, indicating analysts' confidence in the company's guidance increase following stronger-than-expected Q1 results from managed care organizations.
  • Market Trends Support: Analysts noted that improved Medicare Advantage rates, steadier ACA exchange enrollment, and modest Medicaid outperformance have bolstered confidence in margin recovery, despite ongoing cost pressures related to specialty drugs and behavioral health expenses.
  • Management Outlook: Morgan Stanley increased Cigna's price target from $355 to $361, maintaining an Overweight rating, as management meetings highlighted the underappreciated specialty opportunity, with the upcoming September investor day expected to further showcase this long-term strategy.
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
Wall Street analysts forecast CI stock price to rise
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Barclays
Andrew Mok
Overweight
to
Equal Weight
downgrade
$310 -> $304
AI Analysis
2026-05-26
Reason
Barclays
Andrew Mok
Price Target
$310 -> $304
AI Analysis
2026-05-26
downgrade
Overweight
to
Equal Weight
Reason
Barclays analyst Andrew Mok downgraded Cigna to Equal Weight from Overweight with a price target of $304, down from $310.
Barclays
Overweight
to
Equal Weight
downgrade
$310 -> $304
2026-05-26
Reason
Barclays
Price Target
$310 -> $304
2026-05-26
downgrade
Overweight
to
Equal Weight
Reason
Barclays downgraded Cigna to Equal Weight from Overweight with a price target of $304, down from $310. The company has limited potential upside to earnings estimates given its low exposure to government insurance, the analyst tells investors in a research note. The firm says Cigna also faces uncertainty from its pharmacy benefit manager transition and the pace of moderating investment spend. Barclays sees more risk than reward into the company's September investor day due to commercial attrition and AI-driven job cut risk.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cigna Group (CI.N) is 9.41, compared to its 5-year average forward P/E of 10.69. For a more detailed relative valuation and DCF analysis to assess Cigna Group's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.69
Current PE
9.41
Overvalued PE
11.86
Undervalued PE
9.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.82
Current EV/EBITDA
5.23
Overvalued EV/EBITDA
9.83
Undervalued EV/EBITDA
7.82

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.39
Current PS
0.25
Overvalued PS
0.46
Undervalued PS
0.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what sector is undervalued right now
Intellectia · 90 candidates
Market Cap Category: small, mid, large, megaRelative Vol: >= 1.50Pe Ttm: <= 15Ps Ratio: <= 3.00P/B Ratio: <= 3.00Ev Ebitda: <= 12
Ticker
Name
Market Cap$
top bottom
SHEL logo
SHEL
Shell PLC
248.20B
SONY logo
SONY
Sony Group Corp
116.85B
CI logo
CI
Cigna Group
77.07B
NTES logo
NTES
NetEase Inc
72.42B
VALE logo
VALE
Vale SA
67.67B
ACGL logo
ACGL
Arch Capital Group Ltd
32.72B
top stocks in health sector
Intellectia · 38 candidates
Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
866.87B
ABBV logo
ABBV
AbbVie Inc
364.65B
AZN logo
AZN
AstraZeneca PLC
293.00B
MRK logo
MRK
Merck & Co Inc
282.35B
UNH logo
UNH
UnitedHealth Group Inc
254.55B
AMGN logo
AMGN
Amgen Inc
188.63B
give me a selection of long term stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BRevenue 5yr Cagr: >= 8Pe Ttm: 12 - 30Return On Equity: >= 13.0%Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
META logo
META
Meta Platforms Inc
1.66T
JPM logo
JPM
JPMorgan Chase & Co
775.45B
MU logo
MU
Micron Technology Inc
471.24B
MRK logo
MRK
Merck & Co Inc
287.32B
MS logo
MS
Morgan Stanley
255.47B
GS logo
GS
Goldman Sachs Group Inc
244.45B
name me one concrete stock to buy
Intellectia · 28 candidates
Market Cap: >= 10.00BRegion: USQuarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Is Index Component: GSPCOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
DE logo
DE
Deere & Co
163.44B
FE logo
FE
FirstEnergy Corp
28.94B
CTRA logo
CTRA
Coterra Energy Inc
23.80B
MPWR logo
MPWR
Monolithic Power Systems Inc
57.06B
PKG logo
PKG
Packaging Corp of America
22.16B
HUBB logo
HUBB
Hubbell Inc
27.86B
stocks to look into tmr
Intellectia · 9 candidates
Relative Vol: >= 2Is Index Component: GSPCOne Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 5,000,000
Ticker
Name
Market Cap$
top bottom
WAB logo
WAB
Westinghouse Air Brake Technologies Corp
41.66B
ROK logo
ROK
Rockwell Automation Inc
47.41B
EBAY logo
EBAY
eBay Inc
39.08B
IR logo
IR
Ingersoll Rand Inc
38.97B
KKR logo
KKR
KKR & Co Inc
91.54B
EXPE logo
EXPE
Expedia Group Inc
28.41B
which stocks should I buy?
Intellectia · 68 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Can you add a screener for me?A I
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
insiders buying in last 30 days
Intellectia · 505 candidates
Insider Transactions: NetPurchase
Ticker
Name
Market Cap$
top bottom
GE logo
GE
General Electric Co
335.96B
LIN logo
LIN
Linde PLC
205.15B
SPGI logo
SPGI
S&P Global Inc
160.84B
ETN logo
ETN
Eaton Corporation PLC
131.26B
SBUX logo
SBUX
Starbucks Corp
109.65B
NKE logo
NKE
Nike Inc
96.83B
select 5 stocks with strong buy rating
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B
¿Qué acción debería invertir sí o si
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B

Whales Holding CI

S
Simplex Trading, LLC
Holding
CI
+76.69%
3M Return
M
Mubadala Investment Company PJSC
Holding
CI
+59.13%
3M Return
W
Wolverine Trading, LLC
Holding
CI
+29.42%
3M Return
W
Walleye Capital LLC
Holding
CI
+23.07%
3M Return
I
IMC Trading B.V.
Holding
CI
+22.78%
3M Return
B
Bridgewater Associates
Holding
CI
+21.26%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cigna Group (CI) stock price today?

The current price of CI is 277.4 USD — it has decreased -2.44

What is Cigna Group (CI)'s business?

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.

What is the price predicton of CI Stock?

Wall Street analysts forecast CI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cigna Group (CI)'s revenue for the last quarter?

Cigna Group revenue for the last quarter amounts to 68.49B USD, increased 4.57

What is Cigna Group (CI)'s earnings per share (EPS) for the last quarter?

Cigna Group. EPS for the last quarter amounts to 6.26 USD, increased 29.07

How many employees does Cigna Group (CI). have?

Cigna Group (CI) has 67700 emplpoyees as of June 01 2026.

What is Cigna Group (CI) market cap?

Today CI has the market capitalization of 73.38B USD.